InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Cardama Alfonso Quintas, Executive. Director active across 1 company, notably TCR2 THERAPEUTICS INC.. In total, 6 reports have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €14k. Activity tracked since 31 August 2021. The latest transaction was filed on 9 December 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Cardama Alfonso Quintas is a dirigente linked to TCR2 THERAPEUTICS INC. as Chief Medical Officer. He has 6 filings in total, and the sampled recent filings from 2021-12-10 to 2023-06-01 show 0 EUR of purchases and 14377 EUR of sales, with the transaction nature mainly indicated as sell.